Share on Pinterest A new trial finds that GLP-1 agonists may help reduce knee osteoarthritis-related pain. Westend61/Getty ...

The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

Novo Nordisk's drug helped reduce knee pain in osteoarthritis patients with obesity. Meanwhile, the Change Healthcare breach ...

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As weight loss medications like Ozempic continue to gain traction for their ...

By Gina Kolata The blockbuster drug semaglutide, sold as Ozempic for diabetes and as Wegovy for weight loss, now has a new ...

In a groundbreaking new study, Ozempic was found to be so effective at treating arthritis that people no longer needed ...

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...